Among them, chromosome seven amplification leads to high expression of epidermal growth factor EGFR (proto-oncogene), and chromosome eight amplification leads to high expression of proto-oncogene MYC, which promotes tumor progression, suggesting that these patients are at a higher risk of cancer development. The gene discussed is MYC; the disease is neoplasm.